Canada Pension Plan Investment Board’s Acceleron Pharma XLRN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-635	Closed	-$109K	–	1683
2021 Q3	$109K	Buy	+635	New	+$83.1K	﹤0.01%	1259
2021 Q2	–	Sell	-7,991	Closed	-$1.08M	–	1432
2021 Q1	$1.08M	Buy	7,991 +7,329	+1,107%	+$947K	﹤0.01%	985
2020 Q4	$85K	Buy	+662	New	+$77.6K	﹤0.01%	1258

Canada Pension Plan Investment Board's XLRN Position: Q4 2021 in Review

Canada Pension Plan Investment Board sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 635 shares — an estimated $109K sold.

Canada Pension Plan Investment Board first reported a position in XLRN in Q4 2020 and held it in 3 quarters. The position peaked at $1.08M in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Canada Pension Plan Investment Board reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Canada Pension Plan Investment Board sold 635 Acceleron Pharma shares in Q4 2021, an estimated $109K.
Canada Pension Plan Investment Board first reported a position in Acceleron Pharma in Q4 2020 and held it in 3 quarters.
Canada Pension Plan Investment Board's Acceleron Pharma position peaked at $1.08M in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2021, filed 14 Feb 2022.